CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1997; 47:261
doi: 10.3322/canjclin.47.5.261
© 1997 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Eschenbach, A.
Right arrow Articles by Lins, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Eschenbach, A.
Right arrow Articles by Lins, N.

CA: A Cancer Journal for Clinicians, Vol 47, Issue 5 261-264, Copyright © 1997 by American Cancer Society


ARTICLES

American Cancer Society guideline for the early detection of prostate cancer: update 1997

A. von Eschenbach, R. Ho, G. P. Murphy, M. Cunningham and N. Lins
University of Texas M.D. Anderson Cancer Center, Houston, USA.

In summary, the 1997 revision of the ACS guideline for the early detection of prostate cancer is based on knowledge gained by a critical analysis of experience since the original version of 1992. This is only a milestone along a continuous journey rather than being the final destination. Other revisions will be considered when new knowledge becomes available, but for the present, this guideline is offered to health care professionals seeking to provide optimal care to asymptomatic men at risk for prostate cancer.


This article has been cited by other articles:


Home page
Med Decis MakingHome page
C. E. Guerra, P. A. Gimotty, J. A. Shea, J. A. Pagan, J. S. Schwartz, and K. Armstrong
Effect of Guidelines on Primary Care Physician Use of PSA Screening: Results from the Community Tracking Study Physician Survey
Med Decis Making, September 1, 2008; 28(5): 681 - 689.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
P. C. Sorum, E. Mullet, J. Shim, S. Bonnin-Scaon, G. Chasseigne, and J. Cogneau
Avoidance of Anticipated Regret: The Ordering of Prostate-Specific Antigen Tests
Med Decis Making, March 1, 2004; 24(2): 149 - 159.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
P. C. Sorum, J. Shim, G. Chasseigne, S. Bonnin-Scaon, J. Cogneau, and E. Mullet
Why do Primary Care Physicians in the United States and France Order Prostate-Specific Antigen Tests for Asymptomatic Patients?
Med Decis Making, July 1, 2003; 23(4): 301 - 313.
[Abstract] [PDF]


Home page
J Ultrasound MedHome page
F. Shao, K. V. Ling, W. S. Ng, and R. Y. Wu
Prostate Boundary Detection From Ultrasonographic Images
J. Ultrasound Med., June 1, 2003; 22(6): 605 - 623.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Dimitrakopoulou-Strauss and L. G. Strauss
PET Imaging of Prostate Cancer with 11C-Acetate
J. Nucl. Med., April 1, 2003; 44(4): 556 - 558.
[Full Text] [PDF]


Home page
Am. J. Public HealthHome page
S. Lemon, J. Zapka, E. Puleo, R. Luckmann, and L. Chasan-Taber
Colorectal Cancer Screening Participation: Comparisons With Mammography and Prostate-Specific Antigen Screening
Am J Public Health, August 1, 2001; 91(8): 1264 - 1272.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, A. C. von Eschenbach, R. Wender, B. Levin, T. Byers, D. Rothenberger, D. Brooks, W. Creasman, C. Cohen, C. Runowicz, et al.
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection
CA Cancer J Clin, January 1, 2001; 51(1): 38 - 75.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. L. Livant, R. K. Brabec, K. J. Pienta, D. L. Allen, K. Kurachi, S. Markwart, and A. Upadhyaya
Anti-invasive, Antitumorigenic, and Antimetastatic Activities of the PHSCN Sequence in Prostate Carcinoma
Cancer Res., January 1, 2000; 60(2): 309 - 320.
[Abstract] [Full Text]


Home page
NEJMHome page
W. J. Catalona, M. I. Resnick, S. C. Silverstein, B. Bodai, D. C. Hunter, L. M. Schwartz, and S. Woloshin
The Postal Service and Cancer Screening
N. Engl. J. Med., August 12, 1999; 341(7): 542 - 543.
[Full Text]


Home page
The OncologistHome page
A. M. Evens, T. M. Lestingi, and J. D. Bitran
Intermittent Androgen Suppression as a Treatment for Prostate Cancer: A Review
Oncologist, December 1, 1998; 3(6): 419 - 423.
[Abstract] [Full Text]


Home page
J Law Med EthicsHome page
M. M. Collins, F. J. Fowler Jr., R. G. Roberts, J. E. Oesterling, G. J. Annas, and M. J. Barry
Medical Malpractice Implications of PSA Testing for Early Detection of Prostate Cancer
J. Law Med. Ethics, December 1, 1997; 25(4): 234 - 242.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by American Cancer Society.